Article Text

Download PDFPDF

OMERACT 7 psoriatic arthritis workshop: synopsis
  1. D D Gladman1,
  2. V Strand2,
  3. P J Mease3,
  4. C Antoni4,
  5. P Nash5,
  6. A Kavanaugh6
  1. 1University of Toronto, Toronto Western Research Institute, Psoriatic Arthritis Program, University Health Network, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada
  2. 2Division of Immunology and Rheumatology, Stanford University, Palo Alto, CA, USA
  3. 3Seattle Rheumatology Associates; Rheumatology Clinical Research, Swedish Hospital Medical Center; University of Washington School of Medicine, Seattle, WA, USA
  4. 4Department of Medicine-3, Friedrich-Alexander University, Erlangen-Nuremberg, Germany
  5. 5Rheumatology Research Unit, Nambour Hospital, Sunshine Coast; and Department of Medicine, University of Queensland, Queensland, Australia
  6. 6Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology, University of California at San Diego, San Dieago, CA, USA
  1. Correspondence to:
    Dr D Gladman
    Toronto Western Hospital, 399 Bathurst St ECW 5-034B, Toronto, Ontario, M5T 2S8, Canada;


Outcome Measures in Rheumatology (OMERACT) conferences have developed a process by which outcome measures to be included in clinical trials are identified by consensus. During OMERACT 7, held in Asilomar, CA, USA, in May 2004, a workshop on outcome measures in psoriatic arthritis was held. Information derived through a previous Delphi exercise and nominal group process was shared with the participants, as were the results from a study using completed clinical trials with biological therapies. On the basis of the evidence presented and discussions in breakout groups at the OMERACT conference, a set of domains to be included in clinical trials in psoriatic arthritis was developed and a research agenda for further studies in psoriatic arthritis proposed.

  • psoriatic arthritis
  • outcome measures
View Full Text

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.